Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review

Ovarian cancer is the fifth leading cause of cancer death among women and the most lethal gynecologic malignancy. One of the leading causes of death in high-grade serous ovarian cancer (HGSOC) is chemoresistant disease, which may present as intrinsic or acquired resistance to therapies. Here we disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornelison, Robert, Llaneza, Danielle C., Landen, Charles N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666852/
https://www.ncbi.nlm.nih.gov/pubmed/29057791
http://dx.doi.org/10.3390/ijms18102171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666852/
https://www.ncbi.nlm.nih.gov/pubmed/29057791
http://dx.doi.org/10.3390/ijms18102171

Ejemplares similares